Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 77.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 194,674 shares of the company’s stock after selling 667,513 shares during the period. Franklin Resources Inc.’s holdings in Option Care Health were worth $4,516,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. Cornerstone Investment Partners LLC grew its position in shares of Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. Assetmark Inc. grew its holdings in Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock valued at $579,000 after buying an additional 487 shares during the last quarter. Pacer Advisors Inc. increased its position in Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after buying an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management lifted its position in shares of Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after acquiring an additional 550 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $33.69 on Friday. The stock has a market capitalization of $5.53 billion, a P/E ratio of 28.31, a PEG ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business’s fifty day moving average price is $33.23 and its 200 day moving average price is $28.60. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Analyst Ratings Changes

A number of research firms recently commented on OPCH. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research raised their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.